Folks, you landed a premier biotech now don't screw it up. Calistoga has an outstanding PI3K inhibitor and trust me you got a deal on the pipeline. This was a brilliant move by Gilead and surprising given Gilead's leadership.............well done.
are you kidding me.............we will be diversifying too much. I say the move should of been Vertex. We need to own the Hep and ID market. We are too late to the oncology game.
"... too late ..." I remember hearing that in 1997 about HIV. A Geneland clown explained to me how late Gilead was. See ... only PI's mattered. Never too late to do something that saves some lives. Well I guess the "too late" poster has not actually had cancer.